Section Arrow
Quote
MGX.NASDAQ
- Metagenomi Therapeutics Inc.
Quotes are at least 15-min delayed:2026/04/21 22:31 EDT
Regular Hours
Last
 1.5
-0.03 (-1.96%)
Day High 
1.55 
Prev. Close
1.53 
1-M High
1.55 
Volume 
234.10K 
Bid
1.44
Ask
1.52
Day Low
1.4901 
Open
1.54 
1-M Low
1.25 
Market Cap 
57.56M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.42 
20-SMA 1.39 
50-SMA 1.47 
52-W High 3.95 
52-W Low 1.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.36/-2.60
Enterprise Value
92.19M
Balance Sheet
Book Value Per Share
4.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
25.21M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1968-0.0651-24.86%-- 
XRTXXORTX Therapeutics Inc.2.69+0.44+19.56%-- 
TOVXTheriva Biologics Inc0.3387-0.0713-17.39%0.09PE
GERNGeron Corp1.5-0.06-3.85%-- 
SPRCSciSparc Ltd.5.99+1.76+41.61%0PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance itssignature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.